S&P 500   3,916.64
DOW   31,861.98
QQQ   305.30
Risk-Free Money Market vs. Bank Dividend Stock, Which is Better?
Fed's Shocking New Plan to Control Your Money (Ad)
Deal for UBS to buy Credit Suisse sends shares tumbling
Gunmen kill 9 Chinese at mine in Central African Republic
Buy THIS stock before Taiwan is attacked (Ad)
Niinistö: Sweden security OK if Finland joins NATO first
The End of Coca Cola's Compressed Margins
Buy THIS stock before Taiwan is attacked (Ad)
Which Gold Stocks Can Help You Hedge Bank Exposure?
Enphase Energy is Still a Buy for Long-Term Growth Investors
S&P 500   3,916.64
DOW   31,861.98
QQQ   305.30
Risk-Free Money Market vs. Bank Dividend Stock, Which is Better?
Fed's Shocking New Plan to Control Your Money (Ad)
Deal for UBS to buy Credit Suisse sends shares tumbling
Gunmen kill 9 Chinese at mine in Central African Republic
Buy THIS stock before Taiwan is attacked (Ad)
Niinistö: Sweden security OK if Finland joins NATO first
The End of Coca Cola's Compressed Margins
Buy THIS stock before Taiwan is attacked (Ad)
Which Gold Stocks Can Help You Hedge Bank Exposure?
Enphase Energy is Still a Buy for Long-Term Growth Investors
S&P 500   3,916.64
DOW   31,861.98
QQQ   305.30
Risk-Free Money Market vs. Bank Dividend Stock, Which is Better?
Fed's Shocking New Plan to Control Your Money (Ad)
Deal for UBS to buy Credit Suisse sends shares tumbling
Gunmen kill 9 Chinese at mine in Central African Republic
Buy THIS stock before Taiwan is attacked (Ad)
Niinistö: Sweden security OK if Finland joins NATO first
The End of Coca Cola's Compressed Margins
Buy THIS stock before Taiwan is attacked (Ad)
Which Gold Stocks Can Help You Hedge Bank Exposure?
Enphase Energy is Still a Buy for Long-Term Growth Investors
S&P 500   3,916.64
DOW   31,861.98
QQQ   305.30
Risk-Free Money Market vs. Bank Dividend Stock, Which is Better?
Fed's Shocking New Plan to Control Your Money (Ad)
Deal for UBS to buy Credit Suisse sends shares tumbling
Gunmen kill 9 Chinese at mine in Central African Republic
Buy THIS stock before Taiwan is attacked (Ad)
Niinistö: Sweden security OK if Finland joins NATO first
The End of Coca Cola's Compressed Margins
Buy THIS stock before Taiwan is attacked (Ad)
Which Gold Stocks Can Help You Hedge Bank Exposure?
Enphase Energy is Still a Buy for Long-Term Growth Investors
NASDAQ:AKTS

Akoustis Technologies - AKTS Stock Forecast, Price & News

$2.98
+0.06 (+2.05%)
(As of 03/20/2023 08:40 AM ET)
Add
Compare
Today's Range
$2.98
$2.98
50-Day Range
$2.92
$4.80
52-Week Range
$2.28
$7.13
Volume
1,167 shs
Average Volume
844,956 shs
Market Capitalization
$213.22 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$7.06

Akoustis Technologies MarketRank™ Forecast

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
141.9% Upside
$7.06 Price Target
Short Interest
Bearish
6.22% of Shares Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
N/A
Insider Trading
Selling Shares
$10,142 Sold Last Quarter
Proj. Earnings Growth
Growing
From ($0.86) to ($0.44) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.91 out of 5 stars

Computer And Technology Sector

464th out of 608 stocks

Telephone & Telegraph Apparatus Industry

10th out of 11 stocks


AKTS stock logo

About Akoustis Technologies (NASDAQ:AKTS) Stock

Akoustis Technologies, Inc. is a filter solutions company, which engages in the development, design, and manufacture of radio frequency (RF) filter products. It operates through the Foundry Fabrication Services and RF Filters segments. The Foundry Fabrication Services segment is composed of engineering review services and STC-MEMS foundry services. The RF Filters segment includes amplifier and filter product sales, and grant revenue. The company was founded by Jeffrey B. Shealy in 2014 and is headquartered in Huntersville, NC.

Receive AKTS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Akoustis Technologies and its competitors with MarketBeat's FREE daily newsletter.

AKTS Stock News Headlines

Biden To Unleash "Choke Point" Operation On America?
Biden's disturbing new government program may be worse than Obama's. You are at risk for having your bank account frozen. A former bank regulator is blowing the whistle on Biden's frightening plan to take over your money. Discover the immediate steps you need to take now.
12 Most Promising Micro-Cap Stocks According to Analysts
Biden To Unleash "Choke Point" Operation On America?
Biden's disturbing new government program may be worse than Obama's. You are at risk for having your bank account frozen. A former bank regulator is blowing the whistle on Biden's frightening plan to take over your money. Discover the immediate steps you need to take now.
Akoustis Is Entering The Big League
Akoustis Technologies
See More Headlines
Receive AKTS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Akoustis Technologies and its competitors with MarketBeat's FREE daily newsletter.

AKTS Company Calendar

Last Earnings
2/07/2023
Today
3/20/2023
Next Earnings (Estimated)
5/01/2023
Fiscal Year End
6/30/2023

Industry, Sector and Symbol

Industry
Telephone & telegraph apparatus
Sub-Industry
N/A
Current Symbol
NASDAQ:AKTS
Fax
N/A
Employees
156
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$7.06
High Stock Price Forecast
$9.25
Low Stock Price Forecast
$5.00
Forecasted Upside/Downside
+137.0%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
3 Analysts

Profitability

Net Income
$-59,030,000.00
Net Margins
-287.98%
Pretax Margin
-298.02%

Debt

Sales & Book Value

Annual Sales
$15.35 million
Book Value
$1.85 per share

Miscellaneous

Free Float
67,690,000
Market Cap
$213.22 million
Optionable
Not Optionable
Beta
1.74

Key Executives

  • Jeffrey B. ShealyJeffrey B. Shealy
    President, Chief Executive Officer & Director
  • Robert Dry
    Vice President-Operations & Test
  • Kenneth BollerKenneth Boller
    Chief Financial Officer
  • David M. AicheleDavid M. Aichele
    Executive Vice President-Business Development
  • Kamran Cheema
    Chief Product Officer













AKTS Stock - Frequently Asked Questions

Should I buy or sell Akoustis Technologies stock right now?

3 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Akoustis Technologies in the last twelve months. There are currently 3 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" AKTS shares.
View AKTS analyst ratings
or view top-rated stocks.

What is Akoustis Technologies' stock price forecast for 2023?

3 brokerages have issued 12 month target prices for Akoustis Technologies' shares. Their AKTS share price forecasts range from $5.00 to $9.25. On average, they predict the company's share price to reach $7.06 in the next year. This suggests a possible upside of 141.9% from the stock's current price.
View analysts price targets for AKTS
or view top-rated stocks among Wall Street analysts.

How have AKTS shares performed in 2023?

Akoustis Technologies' stock was trading at $2.82 on January 1st, 2023. Since then, AKTS stock has increased by 3.5% and is now trading at $2.92.
View the best growth stocks for 2023 here
.

Are investors shorting Akoustis Technologies?

Akoustis Technologies saw a increase in short interest in February. As of February 28th, there was short interest totaling 4,450,000 shares, an increase of 11.0% from the February 13th total of 4,010,000 shares. Based on an average trading volume of 693,600 shares, the short-interest ratio is currently 6.4 days.
View Akoustis Technologies' Short Interest
.

When is Akoustis Technologies' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, May 1st 2023.
View our AKTS earnings forecast
.

How were Akoustis Technologies' earnings last quarter?

Akoustis Technologies, Inc. (NASDAQ:AKTS) released its quarterly earnings data on Tuesday, February, 7th. The technology company reported ($0.19) EPS for the quarter, beating analysts' consensus estimates of ($0.25) by $0.06. The technology company earned $5.87 million during the quarter, compared to the consensus estimate of $5.91 million. Akoustis Technologies had a negative net margin of 287.98% and a negative trailing twelve-month return on equity of 55.85%.

What ETF holds Akoustis Technologies' stock ?

Defiance Next Gen Connectivity ETF holds 1,220,436 shares of AKTS stock, representing 0.63% of its portfolio.

What guidance has Akoustis Technologies issued on next quarter's earnings?

Akoustis Technologies updated its third quarter 2023 earnings guidance on Wednesday, February, 8th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $7.04 billion-$8.21 billion, compared to the consensus revenue estimate of $7.61 million.

What other stocks do shareholders of Akoustis Technologies own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Akoustis Technologies investors own include Inseego (INSG), NVIDIA (NVDA), Block (SQ), Editas Medicine (EDIT), Marvell Technology (MRVL), Alibaba Group (BABA), Invitae (NVTA), Advanced Micro Devices (AMD), CRISPR Therapeutics (CRSP) and JD.com (JD).

What is Akoustis Technologies' stock symbol?

Akoustis Technologies trades on the NASDAQ under the ticker symbol "AKTS."

Who are Akoustis Technologies' major shareholders?

Akoustis Technologies' stock is owned by a number of retail and institutional investors. Top institutional investors include Silverback Asset Management LLC (3.61%), Senvest Management LLC (2.47%), Needham Investment Management LLC (1.53%), Geode Capital Management LLC (1.45%), Penserra Capital Management LLC (1.42%) and Granahan Investment Management LLC (1.31%). Insiders that own company stock include Arthur Geiss, David Aichele, James Michael Mcguire, Jeffrey B Shealy, Jeffrey B Shealy, Jeffrey Mcmahon, Kenneth Boller, Rohan Houlden, Steven Denbaars and Suzanne B Rudy.
View institutional ownership trends
.

How do I buy shares of Akoustis Technologies?

Shares of AKTS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Akoustis Technologies' stock price today?

One share of AKTS stock can currently be purchased for approximately $2.92.

How much money does Akoustis Technologies make?

Akoustis Technologies (NASDAQ:AKTS) has a market capitalization of $208.93 million and generates $15.35 million in revenue each year. The technology company earns $-59,030,000.00 in net income (profit) each year or ($1.08) on an earnings per share basis.

How many employees does Akoustis Technologies have?

The company employs 156 workers across the globe.

How can I contact Akoustis Technologies?

Akoustis Technologies' mailing address is 9805 NORTHCROSS CENTER COURT SUITE A, HUNTERSVILLE NC, 28078. The official website for the company is www.akoustis.com. The technology company can be reached via phone at (704) 997-5735 or via email at bprag@delmarconsulting.com.

This page (NASDAQ:AKTS) was last updated on 3/20/2023 by MarketBeat.com Staff